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ABSTRACT: Mandelic acids are prototypic chiral molecules where the sensitivity of
crystallized forms (enantiopure/racemic compound/polymorphs) to both conditions
and substituents provides a new insight into the factors that may allow chiral separation
by crystallization. The determination of a signiﬁcant number of single crystal structures
allows the analysis of 13 enantiopure and 30 racemic crystal structures of 21 (F/Cl/Br/
CH3/CH3O) substituted mandelic acid derivatives. There are some common phenyl
packing motifs between some groups of racemic and enantiopure structures, although
they show very diﬀerent hydrogen-bonding motifs. The computed crystal energy
landscape of 3-chloromandelic acid, which has at least two enantiopure and three
racemic crystal polymorphs, reveals that there are many more possible structures, some
of which are predicted to be thermodynamically more favorable as well as slightly denser
than the known forms. Simulations of mandelic acid dimers in isolation, water, and
toluene do not diﬀerentiate between racemic and enantiopure dimers and also suggest
that the phenyl ring interactions play a major role in the crystallization mechanism. The
observed crystallization behavior of mandelic acids does not correspond to any simple “crystal engineering rules” as there is a
range of thermodynamically feasible structures with no distinction between the enantiopure and racemic forms. Nucleation and
crystallization appear to be determined by the kinetics of crystal growth with a statistical bias, but the diversity of the mandelic
acid crystallization behavior demonstrates that the factors that inﬂuence the kinetics of crystal nucleation and growth are not yet
adequately understood.
■ INTRODUCTION
The chirality of biomolecules and their stereospeciﬁc
recognition by receptors in the human body is linked to
fundamental questions about the origins of life and results in
our bodies responding diﬀerently to molecules that are mirror
images of each other. Today, most new small-molecule drugs
are chiral; however, the separation of chiral molecules, with
many identical physical and chemical properties but a distinct
spatial atomic orientation, is a challenge to the chemical and
pharmaceutical industries. Chiral resolution by crystallization
has many advantages over asymmetric synthesis for the large
scale production of enantiopure specialty chemicals.1 The
design of an eﬀective process requires a detailed knowledge of
the phase diagram with a solvent suitable to support resolution2
and exploitation of distinctive characteristics3 based on an
assumption of thermodynamic control of the crystallization
process. Racemic mixtures can crystallize in three diﬀerent
ways, by forming either a conglomerate, racemic compound or,
less frequently, a pseudoracemate.4 Which of these is produced
strongly inﬂuences the way in which the chiral molecules can be
separated, with only conglomerates producing a mixture in
which the two pure enantiomers can be mechanically separated.
However, the assumption that crystallization will result in only
one racemic compound or two separate enantiopure crystal
structures (i.e., a conglomerate) seems unlikely given the extent
of observed5,6 and potential7 polymorphism (multiple crystal
structures containing the same chemical constituents) for
organic molecules. If the experiments lead to the production of
long-lived metastable polymorphs of either the racemic or
enantiopure crystals, then chiral separation by crystallization
runs the risk of the late appearance of a thermodynamically
more stable form. This can lead to loss of control of the
physical and physiological properties of the process and
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product. Polymorph screening techniques8 try to determine all
potential crystal structures of a given molecule and have
advanced considerably in the past 20 years, but no screening
program can guarantee ﬁnding all solid forms. Hence
computational crystal structure prediction methods are being
developed with the aim of helping to identify the most stable
forms9 and to estimate the solubility diﬀerence between the
racemic and enantiopure crystals. To avoid an extensive
research program to determine the potential for chiral
separation by crystallization for each molecule, it would be
valuable to know whether there are general trends for the
existence of alternative crystal structures within families of
molecules. How sensitive are racemic and enantiopure crystal
structures, their polymorphs, and relative solubilities to small
changes in the molecule?
The mandelic acids (Chart 1) are prototypical chiral
molecules that are used as antibacterial agents and cosmetics,
as well as intermediates in industrial synthesis for many
molecules.10 Hence they require a carefully designed separation
process to select the desired enantiomer.1,11 This family of
molecules, with sterically undemanding phenyl ring substituents
which do not compete as hydrogen bond donors, were
independently chosen as a focus of study by the recent
European INTENANT (INTegrated synthesis and puriﬁcation
of single ENANTiomers) project11,12 and a crystal engineering
analysis of the structural systematics of the racemic
compounds.13 In this work, by adding six new enantiopure
crystal structures to this series, we are now able to contrast the
crystal packing and polymorphism of a large series of
enantiopure and racemic crystal structures of mandelic acid
derivatives with the same hydrogen-bonding capabilities. We
have particularly detailed studies of 3ClMA from the
exploration of the binary and ternary phase diagrams10,14 and
characterization by powder X-ray diﬀraction (PXRD) patterns
of two racemic and two enantiopure polymorphs,14 and our
work has identiﬁed further polymorphs. Thus, the ﬁve distinct
structures of 3ClMA, plus the 38 other known crystal structures
of substituted mandelic acids, can be contrasted with the
computer generated structures for 3ClMA. To what extent does
the common hydrogen-bonding capability compete with the
diﬀerent phenyl substituents in controlling the crystal
structures? This analysis of the crystal structures of many
closely related molecules allows us to discuss various
hypotheses that have been put forward as factors that control
the preference for crystallization in racemic structures. These
aﬀect the design of robust crystallization processes for chiral
separation.
■ RESULTS
The diversity of the crystal structures of the set of racemic and
enantiopure mandelic acids studied13 is far greater than in the
known structures of 3ClMA shown in Figure 1. All three
polymorphs of RS-3ClMA are based on the same hydrogen
bonding motif, which includes a hydroxyl−carboxylic acid
carbonyl R2
2(10) dimer (using graph set notation15 where Rd
a(r)
is a ring of r atoms involving a acceptors and d donors). Many
other racemic mandelic acids adopt the R2
2(8) dimer.13 Form 2
of RS-3ClMA is noteworthy for its isostructural packing (i.e.,
matching a cluster of the closest 15 molecules) and yet a
diﬀerent crystallographic cell from Form 1.16 In contrast the
newly determined enantiopure crystal structure (S-3ClMA
Form 1 in Figure 1) is based on a complex hydrogen-bonded
layer including an R2
2(9) motif with disorder in the Cl positions.
This is very diﬀerent from the Form 2 crystal structure of S-
3ClMA, which has four independent molecules in the
asymmetric unit cell (Z′ = 4) and is composed of hydrogen
bonding chains that are linked by an R3
3(11) motif. In the
crystallization of the enantiopure mandelic acids, it was
generally diﬃcult to obtain diﬀraction quality crystals.
Comparison of the 13 enantiopure structures shows that they
adopt ﬁve distinct 3D structures, which are unusually complex
(Figure 2), with only S-4FMA having just one molecule in the
asymmetric unit cell (Z′ = 1). The adoption of high Z′
structures17 by the enantiopure crystals could allow the
formation of either of the two hydrogen-bonded dimers
observed in 27 of the 30 racemic structures13 (which is not
possible for an enantiopure Z′ = 1 structure), but all the
enantiopure crystal structures adopt catemeric hydrogen
bonding motifs. XPac18 analysis of all the mandelic acid crystal
structures (Figure 2) seeking any common packing motifs
between the enantiopure and racemic crystal structures shows
that they have two prevalent one-dimensional packings of the
phenyl groups (1D1 and 1D2 in Figure 2). Hence, it appears
that the packing of the phenyl groups is critical in determining
the crystal structures adopted.
The polymorphism of many of the mandelic acid derivatives
demonstrates that the energy diﬀerences between the crystal
structures may often be small. Several of the racemic
polymorphs were found by seeding with crystals of a very
similar compound,13 and metastable conglomerates were
obtained by seeding with pure enantiomers of other 2-
substituted mandelic acids.11 However, our extensive exper-
imental search for polymorphs of RS-3ClMA (see SI section
1.3) did not ﬁnd further polymorphs among the single crystals
suitable for synchrotron study, though there is some infrared
evidence of further structural diversity.
This extensive series of crystallization experiments on RS-
3ClMA was inspired by the computed crystal energy landscape
(Figure 3). There are four low energy minima in the
conformational energy of isolated 3ClMA (SI Figure 7)
deﬁning four distinct types of possible conformational
polymorphs.19 The search in all four conformational regions
generated over 3000 plausible Z′ = 1 crystal structures within
20 kJ mol−1 of the most stable calculated crystal structure. As
can be observed from the crystal energy landscape (Figure 3),
there is no signiﬁcant diﬀerence in the density and relative
energies of the racemic and enantiopure crystal structures. This
complements the recent observation20 that the structures in the
Chart 1. (a) Mandelic Acid Family, Where the Phenyl
Substituents R2, R3, or R4 Include H, F, Cl, Br, I, CF3, Me,
and OMea and (b) Flexible Torsion Angles in 3ClMA
Considered in the Computational Generation of Crystal
Structures
aThe crystal structures are denoted by chirality (R, S, or RS), the
substituents, and the polymorph, for example, S-3ClMA_2.
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Cambridge Structural Database show no systematic density
diﬀerences between the enantiopure and racemic compounds
and that the energy diﬀerences between racemic and
enantiopure compounds are often small, of the same order as
polymorphic energy diﬀerences, and within the uncertainties of
current computational methods.
It is noticeable that the known crystal structures are lower in
density and higher in energy than many hypothetical structures.
Analyzing the 100 lowest energy structures up to 7 kJ mol−1
above the global minimum shows that there are 20 diﬀerent
hydrogen bonding arrangements (SI Table 4), ﬁve of which are
also observed in the crystal structures of other mandelic acids.
All four conformations are observed, with there being many
pairs of structures that are identical except for the position of
the Cl substituent (i.e., conformation B substituting for A or D
for C, SI Figure 7) and close in energy. There are examples of
the hydrogen bonding producing an enantiopure ribbon or
layer, whose phenyl rings can pack in many ways, producing
both racemic and enantiopure structures.
Even though it has been shown to be successful in many
other CSP studies,9 the obvious question is whether this
method of evaluating the lattice energy is giving a qualitatively
correct picture of the relative stabilities of hypothetical and
observed structures. This is answered by comparing the
energies of the known metastable crystal structures and six
chosen representatives of the hypothetical alternative crystal
packings of 3ClMA (Figure 4 and Figure 5), relative to RS-
3ClMA_3, evaluated with a range of state-of-the-art computa-
Figure 1. An overview of the experimental crystal structures, crystallization conditions (SI, section 1 and refs 14 and 16), and thermodynamic data14
of 3ClMA.
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tional methods. The results are generally in agreement with the
available experimental data (SI Table 1) with the energy
diﬀerence between the two disorder components of form 1 of
S-3ClMA varying most with computational method. The
degree of reranking between diﬀerent methods, shown in
Figure 4, is physically reasonable. The inclusion of environ-
mental eﬀects (either by a polarizable continuum model
(PCM) or by periodic electronic structure methods)
signiﬁcantly aﬀects the energy diﬀerences between hydrogen
bonding motifs. Diﬀerent dispersion corrections change the
relative energies with crystal density. A rigid-body estimate of
Figure 2. Common packing features of the mandelic acid crystal structures derived from pairwise XPac comparison of enantiopure and racemic
crystals. The crystal structures are connected by any common three-dimensional (3D) structures (i.e., isostructural ignoring the substituent), with
3Dx denoting the isotructural relationships for the enantiopure structures and B32 and AB31 being labels from the previous analysis of just the
racemic structures.13 These are related by any common 2D motifs and ﬁnally by the depicted common 1D packing relationships. Packing motif 1D1
is hydrogen−bonded, while 1D2 contains systematic absences. The other 1D relationships are given in SI Figure 2, which also lists the eight crystal
structures not on this diagram. The new crystal structures are denoted by a red box. The background color gives the hydrogen bonding motif: yellow
for catemer, pink for R2
2(8), light blue for R2
2(10), and mauve for both. Only the substituents are given for each of the mandelic acid derivatives, with
MA notation omitted for clarity.
Figure 3. Crystal energy landscape of 3-chloromandelic acid. The
enantiopure structures are denoted by green triangles and racemic
ones by gray diamonds. The lattice energy minima corresponding to
the experimental structures are given in red and were found in the
search if Z′ = 1. Structures shown below the dotted line (at −120 kJ
mol−1) were considered in greater detail (SI Table 7).
Figure 4. Energies of 3ClMA crystals relative to the most
experimentally stable RS Form 3, calculated by diﬀerent methods:
CryOpt, isolated molecule wave functions using CrystalOptimizer; +
PCM, molecular wave functions calculated in a polarizable continuum
(as on Figure 3); + FE, with rigid body free energy estimates; DFT,
periodic PBE density functional calculations with + TS (Tkatchenko−
Scheﬄer) and + G06 (Grimme) dispersion corrections. Closed
triangles denote enantiopure structures and open diamonds denote
racemic structures, with RS forms 1 and 2 frequently superimposed.
Observed structures are joined by solid lines and hypothetical ones by
dashed lines.
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thermal eﬀects has little eﬀect on relative stability, as is usually
the case.21 The variations in energies are consistent with the
challenges in accurately evaluating the lattice energy of even
solid benzene to within 1 kJ mol−1,22 and the need for high
level treatment of methyl vibrational modes to account for the
relative stability of aspirin polymorphs.23 These uncertainties
may account for RS-B2, a structure with a high density and a
less conventional hydrogen bonding motif, being the most
stable for many computational methods. However, RS-A50 is
also close in energy and has the same hydrogen bonding as the
three experimentally determined racemic mandelic acid
structures based on the R2
2(10) dimer (see Figure 5). Even
hypothetical structures, S-A379 and RS-B109, which contain
the hydrogen bonding R2
2(8) dimer also commonly observed in
other racemic mandelic acid structures,13 are competitive in
energy. Hence, there is a detailed and complicated balance
between the various inter- and intramolecular forces (con-
formation, hydrogen bonding, phenyl π stacking, Cl···Cl
halogen bonding), which result in diverse, thermodynamically
competitive structures for 3ClMA. Thus, it is certain that there
are alternative Z′ = 1 enantiopure as well as racemic structures
for 3ClMA that are at least thermodynamically feasible and
possibly more stable than the observed structures.
Figure 5. Hydrogen-bonding motif in the hypothetical crystal structures for 3ClMA, whose energies are compared in Figure 4. The letter gives the
conformation (A or B, see SI Figure 7) and the number from the energy ranking when the structures were generated by CrystalPredictor. The details
of these structures are in SI Table 3.
Figure 6. Low energy isolated dimer structures of 3-ClMA, as optimized by counterpoise-corrected MP2 6-31G(d,p) calculations (See SI Table 2
and section 7.1). The binding energies are given relative to the most stable dimer (SS-R2
2(8)), which has a binding energy of −56.81 kJ mol−1. The
chirality and graph set labels are followed by the two conformer labels, deﬁned by the nearby isolated molecule conformation (SI Figure 7); A is the
lowest energy conformation, B has the Cl on the opposite side, which is only 0.07 kJ mol−1 higher for the isolated molecule, C and D have the two
OH groups on the same side. These labels are also used for mandelic acid dimer types ignoring the Cl.
Journal of the American Chemical Society Article
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The diﬀerences in hydrogen bonding capabilities and the
association of molecules within solution has often been
postulated, and sometimes demonstrated, to control the crystal
form produced.24 Quantum chemical calculations on isolated
dimers of 3ClMA (Figure 6) show that the R2
2(8) hydrogen
bonding motif is more stable than the R2
2(10) motif observed in
the crystal structures but that the interaction energy is almost
independent of whether chirally pure (SS) or racemic (RS)
molecules are their constituents. This has also been found for
isolated mandelic acid dimers.25 However, we note that in most
structures the phenyl rings are so distant in the dimers that this
is not surprising. Only the SS-R2
2(10) dimer brings the phenyl
rings close enough to exhibit a signiﬁcant dispersion
interaction, which is sensitive to the treatment of electron
correlation (SI Table 2). Nonetheless, the dimer formation
does not account for the observed hydrogen bonding motifs in
the RS polymorphs, nor why the enantiopure structures are
catemers.
There is still the possibility that the formation of hydrogen-
bonded dimers in solution could lead to preformed hydrogen-
bonded dimers as eﬀective building blocks in the solid state.
However, FTIR studies25 detect no diﬀerence in the racemic or
enantiopure solutions and no evidence for association into
hydrogen bonding dimers in solutions of methanol, ethanol,
DMF, nitromethane, dioxane, and acetonitrile, but some
evidence of hydrogen bonding in chloroform. Nitromethane
is a nonpolar solvent, like chloroform, and so should not
disrupt the formation of hydrogen bonds. However, the
solvents were not dried and so the presence of trace amounts
of water has the potential to disrupt the hydrogen bonding
where it was otherwise expected to be seen.26 We performed
Molecular Dynamics studies of mandelic acid solutions to
complement these experiments. Simulations of any of the
mandelic acid hydrogen-bonded dimers (RS or SS, R2
2(8) or
R2
2(10)) in water quickly break up into perfectly solvated
separate monomers, producing indistinguishable solutions (SI
section 5.1). Simulations in toluene (SI section 5.2), however,
show the R2
2(8) dimer to be the dominant species, but there are
ﬂuctuations in the hydrogen bonding reminiscent of the R2
2(10)
dimer observed in the crystal structures. This implies that
mandelic acid can easily change hydrogen bonding during
crystallization even in the solvents in which it forms dimers.
Thus, it appears unlikely that hydrogen bonding in solution
persists long enough to play a major role in determining the
polymorph. This is consistent with none of the enantiopure
structures containing either dimer motif and the majority of the
racemic structures containing the R2
2(10) motif.
The simulations of the mandelic acid dimers in toluene also
show no signiﬁcant diﬀerence between the chirally pure (SS)
and racemic (RS) dimers. There are rapid changes from the
phenyl rings being on opposite sides (e.g., RS-R2
2(8)AA, RS-
R2
2(10)BB, and SS-R2
2(8)AC in Figure 6) to being on the same
side of the carboxylic acid group dimer (e.g., SS-R2
2(8)AA, RS-
R2
2(8)AC, SS-R2
2(10)AA in Figure 6). The rate of 12.3 ± 3.0
changes per nanosecond for RS dimers is the same as for the SS
dimers of 11.5 ± 3.2 per nanosecond (SI Table 6). There is no
signiﬁcant diﬀerence in the rapid rate of phenyl rotation, with
8.6 ± 1.1 rotations per nanosecond for the RS and 8.4 ± 1.6 per
nanosecond for the SS dimer. The rapid phenyl rotation of
mandelic acid in water or toluene may explain the chlorine
atom positional disorder and the phenyl ring disorder observed
in some of the crystal structures. Reorganization of the toluene
solvent shell is required to enable phenyl ring rotation. Thus,
while the solvent does have an eﬀect on the rate of
conformational phenyl ring inversions (SI Table 6) of the
monomer and prevalence of hydrogen-bonded dimers, this only
helps explain the formation of diﬀerent polymorphs from
diﬀerent solvents (cf Figure 1 for 3ClMA). The molecular
conformations and hydrogen bonding in solution do not appear
to direct which crystal structures can be adopted. (We are not
considering chiral solvents, which do aﬀect the crystallization of
mandelic acid.27) In water or toluene, the rotational motions
are so fast that it seems unlikely that the crystal growth will be
impeded by the rate of interconversion of conformers of
isolated molecules or dimers in solution.28
■ DISCUSSION
The simple ﬂexible, chiral 3ClMA has a surprisingly complex
crystal energy landscape. Some of the diverse hydrogen
bonding motifs and phenyl interactions in the computer
generated structures for 3ClMA are seen in the crystal
structures for other simply substituted mandelic acids (SI
Table 4). The diversity of the observed mandelic acid structures
is consistent with both the polymorphism of 3ClMA and the
relative computed lattice energies showing no signiﬁcant
thermodynamic advantage for any of observed structures.
Indeed the observed structures for 3ClMA may not be the most
thermodynamically stable, with simpler and equally plausible
hypothetical crystal structures being similar or lower in energy.
The solvent aﬀects the hydrogen bonding in solution, and the
polymorph formed, but the persistence of hydrogen bonds in
solution is not long enough to predetermine the crystal
structure formed.
To explain why the observed structures crystallize and
particularly why the enantiopure structures crystallize so poorly
in such complex structures, when other structures are
thermodynamically competitive, we need to consider the
kinetics of nucleation and growth. Our results show that the
crystallization is not determined by the chiral hydrogen
bonding part of the molecule but appears to be strongly
inﬂuenced by the packing of the phenyl rings. The diversity of
mandelic acid structures and lack of similarities in the solid
phase behavior11 is consistent with strong interactions of the
diﬀerently substituted phenyl groups determining the crystal
structure and growth mechanisms. Many of the computer
generated thermodynamically favorable structures look statisti-
cally unlikely to form from a racemic solution, for example,
structures based on enantiopure layers (e.g., RS-B1335, S-A379,
Figure 5). The complexity of the observed chiral structures is
consistent with them requiring less speciﬁc ordering of the
substituents (cf the disorder in form 1 of S-3ClMA). The
phenyl ring orientation can be swapped in some, but not all, of
the 3ClMA computer generated crystal structures with little or
no eﬀect on the lattice energy, which explains the diﬀerences in
crystallization behavior between the symmetric, 4-substituted
mandelic acids and the asymmetric ones with 2- and 3-
substituents.11,29 Ordering a 2- or 3-substituted phenyl group
during crystal growth will be statistically more diﬃcult. These
factors are in addition to a general statistical “collision
probability” eﬀect that will favor the formation of racemic
over enantiopure nuclei from racemic solutions.11,20 It is also
likely that the opposite enantiomer inhibits the growth of the
enantiopure structures, given the eﬀects of related additives.30
No conglomerate forms from metastable racemic solutions
containing phenyl based molecules that selectively inhibit the
crystallization of the racemic and not chiral mandelic acid,31
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and an additive can promote the crystallization of the
metastable conglomerate of 2ClMA.32 However, the presence
of the other enantiomer is not structure determining because
we have grown the same enantiopure polymorphs of 3ClMA
from racemic solutions, as were found (at least to the
discriminating ability of powder X-ray diﬀraction) in the
separation studies.14
Previously published unexpected features of the crystalliza-
tion of mandelic acids11 support the growth of crystals being a
complex balance of the kinetics of desolvation, conformational
change, phenyl packing, and hydrogen bonding. The phenyl
packing disorder in form 1 of S-3ClMA and its stability relative
to the most stable racemic form is a temperature dependent,
kinetic eﬀect rather than a thermodynamic eﬀect.31 The chiral
form of mandelic acid does not express any polar surfaces,33
suggesting a surface chemistry limitation related to the growth
being aﬀected by phenyl packing more than hydrogen bonding.
Surface structure is very important for the eﬀectiveness of
“tailor-made” additives to enhance chiral separation,34 but
inhibition can also occur.
Deliberate seeding with the desired crystal form is usually
used in industrial crystallization processes to prevent the
production of undesired polymorphs from the stochastic nature
of nucleation. In laboratory experiments, all the crystallized
sample can arise from a single nucleus, as has been shown to
occur in laboratory conditions that should give concomitant
polymorphs of 4-hydroxyacetophenone and isonicotinamide.16
Although considerable eﬀorts are taken in laboratory experi-
ments to avoid seeding with the known form, recent
experiments on the nucleation rate of fenoxycarb (which also
has aromatic and hydrogen bonding functional groups) show a
considerable memory eﬀect unless unusual care is taken with
the solution pretreatment.35 It is rare that a crystallization
experiment can be performed starting from an exactly 50:50
solution of enantiomers with solutions that have no memory of
the input material.36 Once crystallization is initiated, Ostwald
ripening will occur so that the larger crystals grow at the
expense and dissolution of the smaller. Small imbalances in
enantiomers thus get magniﬁed in chiral crystallization. The
determination of ternary phase diagrams seeks quantitative
information about the thermodynamic equilibrium between the
solid and liquid phases, which may not favor the appearance of
some novel thermodynamically competitive polymorphs.
Heterogeneous seeding can be structure determining for the
mandelic acids as shown by our use of isostructural cross-
seeding to generate13 a new polymorph of RS-3MeMA and new
metastable conglomerates by seeding with S-2ClMA.11
Inadvertent seeding particularly through structurally related
impurities can also play a major role, as shown particularly
dramatically in the case of ritonavir, where heterogeneous
nucleation from a degradation product appeared to be
responsible for the ﬁrst appearance of a signiﬁcantly more
stable form.37 This is just one example of the late appearance
and apparent disappearance of polymorphs.38
A similar lack of a link between solution chemistry and
crystallization outcome has recently been demonstrated for the
conformational polymorphs of tolfenamic acid39 highlighting
the challenges in experimentally determining the kinetic factors
involved in nucleation and growth. Given the diﬃculty in
obtaining the ﬁrst diﬀraction quality crystals of the enantiopure
mandelic acids, it seems likely that chance and kinetics play a
major role in determining which of the thermodynamically
competitive crystal structures crystallizes ﬁrst. After that,
memory eﬀects and inadvertent seeding might favor the growth
of the known forms and reduce the chance of observing further
polymorphs.
Mandelic acids have long been acknowledged to present
more complex crystallization behavior than is usually expected
for small organic molecules, despite being the prototype for
chiral separation studies. However, their crystal structures being
a compromise between molecular ﬂexibility, hydrogen bonding,
and van der Waals interactions makes them a prototype for
many pharmaceutical molecules, which also have substituted
aromatic groups ﬂexibly linked to polar hydrogen bonding
regions. Pharmaceuticals often have many thermodynamically
equivalent modes of packing. Small changes in substituents or
the presence of chemically related impurities can have a
dramatic eﬀect on the ability to crystallize a pharmaceutical
molecule, let alone its crystal structure. The mandelic acids
show the diﬃculties in understanding nucleation and crystal
growth suﬃciently well to be able to rationally design a range of
experiments to conﬁrm that all practically important poly-
morphs have been found5,7,40 or to predict the phase diagrams
adequately. However, once this has been achieved, there are
potential beneﬁts for the rational design of separation1 and
other crystallization processes40 to improve the quality of the
ﬁnal product. When the thermodynamic diﬀerence between
racemic and enantiopure forms and their polymorphs is small,
there is a potential advantage that the kinetic factors may be
more readily controlled by appropriate choice of solvent,
temperature, and seeding to drive a satisfactory process.
■ CONCLUSIONS
This overview of the enantiopure and racemic crystal structures
adopted by simply substituted mandelic acids reveals that a
wide range of crystal packings are observed and thermodynami-
cally competitive. The packing of the phenyl groups (which is
aﬀected by the substituents) balances with a variety of
hydrogen bonding motifs and conformational ﬂexibility to
give structural diversity. This diversity deﬁes simple explan-
ations of chiral crystallization. Our experimental work has
found a signiﬁcant degree of polymorphism, though even in the
case of racemic 3ClMA, the screening is far from complete by
industrial standards. Nonetheless, the relationship between the
computed crystal energy landscape for 3ClMA and the diversity
of substituted mandelic acid crystal structures raises the
question of why simpler enantiopure and more forms of
racemic mandelic acids have not been found so far.
Analyzing the new enantiopure crystal structures in contrast
with the racemic structures shows that phenyl packing is
strongly aﬀecting crystal nucleation and growth. Statistical
probability also plays a role in determining which structures are
found and in the diﬃculty in crystallizing the enantiopure
structures. The association of molecules in some solvents is not
suﬃciently strong to determine the crystal structures. There is a
substitution-dependent struggle to pack the phenyl groups
correctly during crystal growth, while simultaneously forming
various hydrogen bonding motifs. The formation of the initial
nucleus is therefore a key step in determining which structures
are formed. Some computer-generated thermodynamically
plausible crystal structures are statistically unlikely to form,
though this might occur in the presence of speciﬁc impurities or
surfaces. Understanding nucleation well enough to determine
whether a given thermodynamically favorable crystal structure
can be made to nucleate is a fundamental scientiﬁc challenge. In
practice, seeding and Ostwald ripening play a signiﬁcant role in
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ensuring that crystallization usually results in only one racemic
and one enantiopure phase.
A compensating advantage of crystallization being a subtle
and complex balance of competing kinetic eﬀects of nucleation
and growth between thermodynamically competitive structures
is the potential for ﬁnding new solid forms with improved
physical properties. It also allows the design of processes for
chiral separation1 of a wider range of molecules by careful
tailoring of conditions.
■ MATERIALS AND METHODS
The materials and methods used to produce all of the crystal structures
reported, except RS-3ClMA form 3, have been previously reported by
the Magdeburg group.11,41
RS-3ClMA form 3 has a P21/c, Z′ = 1, structure with a =
8.6234(12) Å, b = 10.4812(14) Å, c = 9.3924(13) Å, β = 93.846(7)°,
and V = 847.007 Å3. The single crystal was obtained from
dichloromethane, from material produced via cyanohydrin synthesis
from 3-Cl benzaldehyde sourced from Alfa. The crystals of S-3ClMA
form 1 (P21, Z′ = 2, crystals; a = 8.3160(18) Å, b = 11.855(3) Å, c =
8.4526(18) Å, β = 93.820(7)°, and V = 831.458 Å3) exhibit full
molecule disorder in the ratio 2:1. The major and minor component
are both ordered crystal structures containing the molecule with bond
lengths and angles close to those observed in other 3ClMA structures,
so two ordered models can be derived for calculations, diﬀering in the
placement and geometry of the second molecule, denoted S-3ClMA
form 1_A and S-3ClMA form 1_B for the major and minor
components, respectively. S-3ClMA form 2 is a P21, Z′ = 4, structure
with a = 9.8701(8) Å, b = 5.4344(6) Å, c = 30.656(2) Å, β =
95.260(8)°, and V = 1637.4 Å3.
The other new mandelic acid crystal structures are S-3MeMA, a P21,
Z′ = 4, structure with a = 10.0845(9) Å, b = 5.3717(5) Å, c =
30.358(4) Å, β = 91.800(12)°, and V = 1643.71 Å3; S-3BrMA, a P21,
Z′ = 4, structure with a = 9.7454(19) Å, b = 5.5417(6) Å, c =
31.396(4) Å, β = 95.094(15)°, and V = 1688.88 Å3; S-2Cl4FMA, a
P21, Z′ = 2, structure with a = 7.8577(8) Å, b = 7.8314(6) Å, c =
14.1039(12) Å, β = 105.477(10)°, and V = 836.436 Å3; S-4Cl2FMA
having whole molecule disorder in a P21, Z′ = 2, structure with a =
7.9508(7) Å, b = 7.0951(9) Å, c = 15.8626(15) Å, β = 95.565(9)°, and
V = 890.619 Å3; and RS-4Cl2FMA, a P1 ̅, Z′ = 4, structure with a =
7.7848(5) Å, b = 13.5323(10) Å, c = 16.7476(18) Å, α = 96.955(8)°, β
= 99.289(8)°, γ = 90.680(6)°, and V = 1727.46 Å3.
Computational Methods. Crystal structures were compared in a
pairwise fashion using XPac,18 using the non-hydrogenic atoms of
mandelic acid to determine whether there were any supramolecular
constructs in common between the enantiopure and racemic
structures. This supplements the analysis of the racemic structures.13
The 3ClMA structures were also visualized and overlaid using the
Crystal Packing Similarity tools in Mercury.42
The ﬂexibility of 3ClMA leads to four local conformational minima
(SI Figure 7) and a wide range of the ﬂexible torsion angles (Chart 1)
that are suﬃciently low in energy to be possible crystal
conformations.19 The search was based on separating the lattice
energy into the intermolecular contribution, Uinter, and the energy
penalty, ΔEintra, for changing the molecular conformation, that is, Elatt
= Uinter + ΔEintra.43 Ab initio calculations on the isolated molecule using
Gaussian0344 at the MP2/6-31G(d,p) level were used for ΔEintra and
were analyzed by GDMA to give the distributed multipole
representation of the charge density45 used in DMACRYS43 for the
electrostatic component of the lattice energy. All other intermolecular
energies were represented by an isotropic atom−atom exp-6 potential,
using the parameters of the FIT potential.43
CrystalPredictor46 was used to generate approximately one million
Z′ = 1 crystal structures in each conformational region. The most
promising 3500 unique structures were reﬁned using CrystalOptim-
izer.47 Full details and the crystal energy landscape at this stage are in
SI Figure 8. To approximate the eﬀect of the crystalline environment
on the charge distribution and conformational energies,48 we
estimated the eﬀect of polarization through a polarizable continuum
model (PCM)49 using the MP2 wave function with a dielectric
constant of ε = 3. This is the crystal energy landscape in Figure 3. To
estimate the eﬀects of temperature on the relative stability, a rigid
molecule harmonic estimate of the Helmholtz free energy, including
the zero-point vibrational energy,50 was made from the elastic
constants51 and k = 052 phonons.
Alternative estimates of the lattice energy were obtained using
periodic electronic structure calculations, namely, a plane wave DFT-D
approach using the CASTEP53 code with the PBE functional and
either a Grimme (G06)54 or Tkatchenko−Scheﬄer (TS)55 dispersion
correction with full optimization.
Estimates of the binding energy of the dimers in isolation were
performed using Gaussian03 using MP2 perturbation theory and a 6-
31G(d,p) basis set and corrected for the basis set superposition error
with the Counterpoise keyword.
The solution simulations started from quantum chemically
optimized dimer structures of R- and S-mandelic acid positioned in
the center of a cubic box of dimensions 30 × 30 × 30 Å3 for water and
45 × 45 × 45 Å3 for toluene. Parametrization of the mandelic acid
molecules was done with ParamChem0.9.7.1beta.56 The mandelic acid
dimers were solvated in explicit TIP3 water57 using VMD. 1.9.158 and
its solvate plugin 2 and in explicit toluene using an internal protocol;
782 water molecules and 498 toluene molecules were positioned in a
radius of 3 Å around the solutes. Molecular dynamics simulations were
performed using NAMD 2.959 with the CHARMM36 force ﬁeld60 and
the CGenFF2B8 force ﬁeld for small molecules.61 A nonbonding a
cutoﬀ of 12 Å, a switch distance of 10 Å, and a pair list distance of 14 Å
were set. Every simulation was done in a NVT-ensemble at 293 K,
controlled by a Langevin Thermostat62 with a damping coeﬃcient of
1/ps and coupled hydrogens. Periodic boundary conditions were
applied. Interactions were computed using the PME method63 with a
grid of 60 × 60 × 60 Å3 for water and 90 × 90 × 90 Å3 for toluene.
The integrator utilized a time step of 1 fs, the nonbonded interactions
were computed at every step, and the atoms were reassigned every 20
steps. The system setup was minimized for 5000 steps, and production
runs ran for 107 steps (10 ns). The trajectory was collected every 2500
steps.
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